Amrep (AXR - Get Report) was downgraded to sell at TheStreet Ratings. You can view the full analysis from the report here: AXR.
Bioverativ ( BIVV) was downgraded from buy to neutral, Goldman Sachs said. It has a $55 price target. The company is facing increased competition.
Rockwell Collins ( COL) was upgraded to overweight, Morgan Stanley said. It has a $121 price target. The BEAV acquisition could add as much as 30% to earnings.
Johnson Controls ( JCI - Get Report) was downgraded from buy to neutral, Goldman Sachs said. It has a $44 price target. Analysts see a limited downside to synergy targets.